share_log

Goldman Sachs Maintains Buy on BrightSpring Health, Lowers Price Target to $23

Goldman Sachs Maintains Buy on BrightSpring Health, Lowers Price Target to $23

高盛維持對BrightSpring Health的買入,將目標股價下調至23美元
Benzinga ·  03/04 09:23

Goldman Sachs analyst Jamie Perse maintains BrightSpring Health (NASDAQ:BTSG) with a Buy and lowers the price target from $26 to $23.

高盛分析師傑米·珀斯維持BrightSpring Health(納斯達克股票代碼:BTSG)的買入並將目標股價從26美元下調至23美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論